Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement

Franklin Genomic Advancements ETF

This ETF provides exposure to Other Global Equities

HELX performance and flow charts

Last update 9/14/2026 at 5:12 PM
Live
Closed
Last price
$41.56
+$0.57 (+1.40%) Today

Performance

-2.00.02.04.06.0%Aug 11Aug 18Aug 25Sep 1Sep 9

Flows

0
1 day price range
$41.56
$41.56
52 week price range
$29.86
$43.49
1W perf
-2.18%
YTD perf
+12.93%
YTD flows
+$6M
AuM
$31M
E/R
0.5%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 11, 2026
1M3MYTD1Y3Y5Y
Perf.-1.05%+15.09%+12.93%+33.15%+37.37%-26.59%
Flows-+$4M+$6M+$8M+$15M+$4M
Data as of September 11, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderFranklin Templeton
N° of holdings66
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateFebruary 25, 2020
ESGNo
TrackinsightTrackinsight

More data and info about HELX on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

60.19%

Total weight of top 15 holdings out of 66

Top 15 Holdings

Guardant Health, Inc.
9.1%
Natera, Inc.
7.31%
Krystal Biotech, Inc.
6.17%
Ligand Pharmaceuticals, Inc.
4.48%
Adaptive Biotechnologies Corp.
4.33%
BridgeBio Pharma, Inc.
4.08%
United Therapeutics Corp.
3.52%
Eli Lilly & Co.
3.04%
Vertex Pharmaceuticals, Inc.
2.73%
SAMSUNG BIOLOGICS Co., Ltd.
2.72%
Travere Therapeutics, Inc.
2.67%
Corteva, Inc.
2.65%
AstraZeneca PLC
2.49%
Twist Bioscience Corp.
2.47%
Medpace Holdings, Inc.
2.44%

Sectors

Healthcare
96.35%
Other
3.65%

Countries

USA
86.99%
Other
13.01%

Trading data

Last sale
9/14/2026 at 5:12 PM
$41.56
Previous close
$40.99
Consolidated volume
09/11/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+24.44%+22.84%+21.42%+23.54%
Max drawdown
-6.59%-17.89%-29.16%-58.16%
Max drawdown duration
28d206d458d1814d
Time to recover
18d90d193dN/A
Advertisement
Frequently asked questions about HELX

What type of ETF is HELX?

HELX is a Active ETF that provides exposure to Equity assets. It is managed by Franklin Templeton.

What does HELX invest in?

This ETF provides exposure to Other Global Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of HELX?

The total expense ratio (TER) of HELX is 0.5%, representing the annual fee charged by the fund manager.

When was HELX launched?

HELX was launched on February 25, 2020, marking its entry into the ETF market.

Who is the issuer of HELX?

HELX is issued by Franklin Templeton.

What is the AUM of HELX?

As of September 11, 2026, HELX manages $30.73 M, reflecting the total assets held in the fund.

How has HELX performed recently?

As of September 11, 2026, HELX delivered a return of -1.05% over the past month (1M performance), 15.09% over the past three months (3M), and 12.93% year-to-date (YTD).

How many holdings are in HELX

As of July 31, 2026, HELX holds 66 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is HELX?

As of July 31, 2026, HELX holds 66 securities, with 60.19% of its assets concentrated in its top 15 holdings.

What are the top holdings of HELX?

As of July 31, 2026, HELX holds a portfolio of 66 underlyings, with its largest positions including Guardant Health, Inc., Natera, Inc. and Krystal Biotech, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does HELX invest in?

As of July 31, 2026, HELX has its largest geographic exposures in USA.

What sectors or themes does HELX focus on?

As of July 31, 2026, HELX is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder